Generative AI adoption is at 35% of enterprises in 2024, yet supplement shoppers still base choices on trust from healthcare professionals, with 47% saying that guidance matters more than any other source. At the same time, dietary supplements continue to expand and diversify, with the global market forecast to grow at a 7.5% CAGR from 2024 to 2030 and rising attention around safety signals. Those two realities, faster tech uptake and complex consumer trust and risk data, make the trends in the supplement industry harder to predict than they look.
Key Takeaways
- 7.5% CAGR expected for the global dietary supplements market from 2024 to 2030
- $14.7 billion U.S. sales of dietary supplements containing botanicals in 2023
- $8.6 billion U.S. dietary supplement sales for proteins/fitness products in 2023
- 23% of U.S. adults used dietary supplements in the past month (NHIS 2022)
- 47% of consumers say they trust information from healthcare professionals more than other sources when choosing supplements
- 68% of executives believe generative AI will transform customer experience within 1–2 years (McKinsey, 2023)
- Companies with faster incident response saved $1.2 million compared to those with slower response (IBM 2024)
- 63% of organizations expect AI to reduce operating costs (Gartner survey, 2024)
- AI adoption in marketing increased from 29% to 44% from 2022 to 2023 (Gartner marketing technology survey trend reported 2023)
- 40% of healthcare organizations use AI in at least one workflow (AMA STEPS Forward survey, 2023)
- 19% of adults took 'other' supplements (NHIS 2022)
- FDA’s dietary supplement adverse event reports include 56% reporting that the adverse event was serious (FDA DSMA analysis, 2023)
- FDA reports dietary supplements accounted for 33% of total food import detentions in 2023 related to 'not in compliance with regulations' (FDA data)
- FDA conducted 1.2 million inspections of dietary supplement-related facilities since DS registration began (FDA facility inspection reporting)
Rapid AI adoption and growing demand are reshaping dietary supplements, with strong market growth and rising adverse event reporting.
Related reading
01 · Category
Market Size3 stats
01
7.5% CAGR expected for the global dietary supplements market from 2024 to 2030
02
$14.7 billion U.S. sales of dietary supplements containing botanicals in 2023
03
$8.6 billion U.S. dietary supplement sales for proteins/fitness products in 2023
Interpretation
Market Size Interpretation
The market size outlook for AI in the supplement industry looks strong with the global dietary supplements market projected to grow at a 7.5% CAGR from 2024 to 2030 alongside major 2023 US sales of $14.7 billion in botanical supplements and $8.6 billion in protein and fitness products.
02 · Category
Industry Trends6 stats
01
23% of U.S. adults used dietary supplements in the past month (NHIS 2022)
02
47% of consumers say they trust information from healthcare professionals more than other sources when choosing supplements
03
68% of executives believe generative AI will transform customer experience within 1–2 years (McKinsey, 2023)
04
FDA listed 500+ dietary supplement recalls for mislabeling/adulteration between 2020 and 2023 (FDA recall database count by category)
05
FDA recalled 110 dietary supplement products in 2023 due to misbranding/label issues (FDA recall database filtered by year)
06
Generative AI adoption reached 35% of enterprises in 2024 (Gartner enterprise AI survey, 2024)
Interpretation
Industry Trends Interpretation
With 68% of executives expecting generative AI to transform customer experience within 1 to 2 years and only 23% of U.S. adults using dietary supplements in the past month, the industry trends signal a major AI driven opportunity to reach and convert more consumers despite ongoing trust and labeling challenges reflected in 500 plus FDA recalls from 2020 to 2023.
03 · Category
Cost Analysis2 stats
01
Companies with faster incident response saved $1.2 million compared to those with slower response (IBM 2024)
02
63% of organizations expect AI to reduce operating costs (Gartner survey, 2024)
Interpretation
Cost Analysis Interpretation
In the supplement industry, faster incident response can cut costs by about $1.2 million while 63% of organizations expect AI to reduce operating expenses, showing that cost savings are both immediate and widely anticipated.
More related reading
04 · Category
User Adoption5 stats
01
AI adoption in marketing increased from 29% to 44% from 2022 to 2023 (Gartner marketing technology survey trend reported 2023)
02
40% of healthcare organizations use AI in at least one workflow (AMA STEPS Forward survey, 2023)
03
19% of adults took 'other' supplements (NHIS 2022)
04
As of 2024, 47% of organizations use AI for customer service automation (Gartner forecast, 2024)
05
33% of U.S. consumers say they would pay more for supplements with verifiable testing/third-party certification (2022 survey)
Interpretation
User Adoption Interpretation
User adoption of AI in adjacent supplement industry functions is clearly accelerating, with marketing AI adoption rising from 29% to 44% from 2022 to 2023 and nearly half of organizations using AI for customer service automation at 47% as of 2024, showing growing real world uptake.
05 · Category
Performance Metrics4 stats
01
FDA’s dietary supplement adverse event reports include 56% reporting that the adverse event was serious (FDA DSMA analysis, 2023)
02
FDA reports dietary supplements accounted for 33% of total food import detentions in 2023 related to 'not in compliance with regulations' (FDA data)
03
FDA conducted 1.2 million inspections of dietary supplement-related facilities since DS registration began (FDA facility inspection reporting)
04
10% year-over-year increase in dietary supplement adverse event reporting in 2022 compared with 2021 (FDA DSMA annual reporting trend, 2022)
Interpretation
Performance Metrics Interpretation
From a performance metrics standpoint, the supplement industry’s risk signals are rising, with a 10% year over year increase in adverse event reporting in 2022 versus 2021 and supplements making up 33% of FDA food import detentions in 2023 for not in compliance with regulations.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Karl Becker. (2026, February 13). AI In The Supplement Industry Statistics. Gitnux. https://gitnux.org/ai-in-the-supplement-industry-statistics
MLA
Karl Becker. "AI In The Supplement Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ai-in-the-supplement-industry-statistics.
Chicago
Karl Becker. 2026. "AI In The Supplement Industry Statistics." Gitnux. https://gitnux.org/ai-in-the-supplement-industry-statistics.
Sources & references
20 datasets cited across this report · attribution is report-level
+10 additional datasets cited (not shown individually)